Evidence map›Paper›PMID 29568343›Full record

ArticleOncotarget2018

The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome.

Jean-François Bureau, Patricia Cassonnet, Laura Grange, Julien Dessapt, Louis Jones, Caroline Demeret, Anavaj Sakuntabhai, Yves Jacob

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jean-François BureauUnité de Génétique Fonctionnelle des Maladies Infectieuses, Département Génome et Génétique, Institut Pasteur, Paris, France.
Patricia CassonnetUnité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.
Laura GrangeUnité de Génétique Fonctionnelle des Maladies Infectieuses, Département Génome et Génétique, Institut Pasteur, Paris, France.
Julien DessaptUnité de Génétique Fonctionnelle des Maladies Infectieuses, Département Génome et Génétique, Institut Pasteur, Paris, France.
Louis JonesUnité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.
Caroline DemeretUnité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.
Anavaj SakuntabhaiUnité de Génétique Fonctionnelle des Maladies Infectieuses, Département Génome et Génétique, Institut Pasteur, Paris, France.
Yves JacobUnité de Génétique Moléculaire des Virus à ARN, Département Virologie, Institut Pasteur, Paris, France.
Centre National de la Recherche Scientifique · FRCentre de Gestion Scientifique · FRDélégation Paris 7 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SRC Kinase Adaptor Phosphoprotein 2 (SKAP2) is a broadly expressed adaptor associated with the control of actin-polymerization, cell migration, and oncogenesis. After activation of different receptors at the cell surface, this dimeric protein serves as a platform for assembling other adaptors such as FYB and some SRC family kinase members, although these mechanisms are still poorly understood. The goal of this study is to map the SKAP2 interactome and characterize which domains or binding motifs are involved in these interactions. This is a prerequisite to finely analyze how these pathways are integrated in the cell machinery and to study their role in cancer and other human diseases when this network of interactions is perturbed. In this work, the domain and the binding motif of fourteen proteins interacting with SKAP2 were precisely defined and a new interactor, FAM102A was discovered. Herein, a fine-tuning between the binding of SRC kinases and their activation was identified. This last process, which depends on SKAP2 dimerization, indirectly affects the binding of FYB protein. Analysis of conformational changes associated with activation/inhibition of SRC family members, presently limited to their effect on kinase activity, is extended to their interactive network, which paves the way for therapeutic development.

Indexed as

adaptorFYBluciferase complementation assayPathologyprotein-protein interactionSRC-kinase family

Identifiers

PMID29568343
PMCPMC5862564
OpenAlexW2792208862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.